PacBio and Covaris Partner to Advance Cancer Tumor Sequencing with HiFi Technology

Key Facts

1PacBio and Covaris announced a joint workflow enabling HiFi long-read sequencing of FFPE tumor samples.

2The collaboration aims to improve genetic data extraction from archived clinical samples for cancer research.

PacBio and Covaris have announced a joint workflow designed to enable HiFi long-read sequencing of Formalin-Fixed Paraffin-Embedded (FFPE) tumor samples. This collaboration aims to significantly improve genetic data extraction from archived clinical samples, which are critical for cancer research. By combining advanced extraction techniques with streamlined library preparation, the partnership addresses the technical challenges of sequencing degraded DNA. This integration is expected to expand PacBio's addressable market within the clinical oncology sector. The move highlights a strategic effort to enhance the utility of long-read sequencing in precision medicine. Analysts view this technical milestone as a positive development for PacBio's competitive positioning in the genomics industry.